Comparison Of A Novel Sling With A Traditional Abduction Sling After Shoulder Surgery

June 13, 2022 updated by: Keith Baumgarten, Orthopedic Institute, Sioux Falls, SD

Randomized Trial Comparing A Novel Sling With A Traditional Abduction Sling After Shoulder Surgery

The objective of this study is to determine if the novel shoulder sling has higher patient satisfaction compared to a traditional, abduction sling with at least equivalent postoperative outcomes after arthroscopic rotator cuff repair and total shoulder arthroplasty.

Study Overview

Detailed Description

Specific Aim I:

To determine if patients undergoing arthroscopic rotator cuff repair prefer the traditional abduction sling vs the novel sling.

Specific Aim II:

To determine if patients undergoing total shoulder arthroplasty prefer the traditional abduction sling vs the novel sling.

Specific Aim III:

To determine if short term follow-up (2, 4, 6 weeks), subjective patient-reported outcomes are superior in patients utilizing the novel sling compared to patients utilizing the traditional, abduction sling.

Specific Aim IV:

To determine if longer term follow-up (6 weeks, 14 weeks, 6 months, and 12 months), validated patient-reported outcomes are similar (non-inferior) in patients utilizing the novel sling compared to a historical control cohort of patients that only utilized the traditional, abduction sling. The purpose of this aim is to ensure that patients that utilize the novel novel sling for 2 to 4 weeks (with the traditional sling used for the rest of the 6 week period) do not have inferior outcomes compared to patients that have worn the traditional sling for a total of 6 weeks.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Khris Loe
  • Phone Number: 605 339 6828

Study Locations

    • South Dakota
      • Sioux Falls, South Dakota, United States, 57117
        • Recruiting
        • Orthopedic Institute
        • Contact:
          • Keith M Baumgarten, MD
          • Phone Number: 605-331-5890

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing arthroscopic rotator cuff repair and anatomic total shoulder arthroplasty
  • Dominant extremity undergoing surgery

Exclusion Criteria:

  • Patients undergoing revision surgery
  • Patients with a history of significant cervical spine disease, peripheral neuropathy, or concomitant wrist or elbow disorders
  • Patients that do not understand English
  • Patients unwilling to participate or follow up for the study protocols

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Initial Immobilization with the novel sling
20 patients will be placed in the novel sling after surgery for the first two weeks. For the second two weeks (days 15-28) they will crossover and utilize the standard abduction sling. For the final two weeks (days 29-42) they will choose their preferred sling type and use it for the remainder of six week immobilization period.
The novel sling was designed and created by the principal investigator to address these concerns of the traditional slings that are currently available for postsurgical protection and immobilization after shoulder surgery. It is anticipated that the novel sling will allow the patient to be more active and more comfortable while still providing a safe healing environment after a shoulder injury or shoulder surgery.
Experimental: Initial Postoperative Immobilization with the standard abduction sling
20 patients will be placed in the traditional abduction sling after surgery for the first two weeks. For the second two weeks (days 15-28) they will crossover and utilize the novel sling. For the final two weeks (days 29-42) they will choose their preferred sling type and use it for the remainder of six week immobilization period.
An abduction sling is the most common type of sling utilized to protect patients after rotator cuff surgery and total shoulder of arthroplasty and can be considered the current standard of care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient choice of type of sling to utilize from postoperative days 29-42
Time Frame: 6 weeks after surgery
Categorical variable of which sling they preferred to use for the last two weeks of their 6 week postoperative immobilization period
6 weeks after surgery
Sling satisfaction survey
Time Frame: Prior to surgery
a novel, sling satisfaction score (SSS)[scale 0= best to 10=worst] utilizing a number-based visual analog scale will be utilized to assess baseline characteristics of common symptoms that have been attributed to sling use
Prior to surgery
Sling satisfaction survey
Time Frame: 14 days after surgery
a novel, sling satisfaction score (SSS) [scale 0= best to 10=worst] utilizing a number-based visual analog scale will be utilized to assess baseline characteristics of common symptoms that have been attributed to sling use and satisfaction with the type of sling utilized during this time period
14 days after surgery
Sling satisfaction survey
Time Frame: 15 days after surgery
a novel, sling satisfaction score (SSS) [scale 0= best to 10=worst] utilizing a number-based visual analog scale will be utilized to assess baseline characteristics of common symptoms that have been attributed to sling use and satisfaction with the type of sling utilized during this time point. The rationale for recording both the day 14 and day 15 SSS is to get the patient's immediate impression on the potential subjective differences between the slings within 24 hours of changing to the alternate sling.
15 days after surgery
Sling satisfaction survey
Time Frame: 28 days after surgery
a novel, sling satisfaction score (SSS) [scale 0= best to 10=worst]utilizing a number-based visual analog scale will be utilized to assess baseline characteristics of common symptoms that have been attributed to sling use and satisfaction with the type of sling utilized during this time period
28 days after surgery
Sling satisfaction survey
Time Frame: 6 weeks after surgery
a novel, sling satisfaction score (SSS) [scale 0= best to 10=worst] utilizing a number-based visual analog scale will be utilized to assess baseline characteristics of common symptoms that have been attributed to sling use and satisfaction with the type of sling utilized during this time period
6 weeks after surgery
Sling satisfaction survey
Time Frame: 14 weeks after surgery
a novel, sling satisfaction score (SSS) [scale 0= best to 10=worst] utilizing a number-based visual analog scale will be utilized to assess baseline characteristics of common symptoms that have been attributed to sling use
14 weeks after surgery
Sling satisfaction survey
Time Frame: 6 months after surgery
a novel, sling satisfaction score (SSS) [scale 0= best to 10=worst] utilizing a number-based visual analog scale will be utilized to assess baseline characteristics of common symptoms that have been attributed to sling use
6 months after surgery
Sling satisfaction survey
Time Frame: 12 months after surgery
a novel, sling satisfaction score (SSS) [scale 0= best to 10=worst] utilizing a number-based visual analog scale will be utilized to assess baseline characteristics of common symptoms that have been attributed to sling use
12 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder Activity Level
Time Frame: 6 months after surgery
A validated shoulder-specific activity score (low 0 - 20 high)
6 months after surgery
Shoulder Activity Level
Time Frame: 12 months after surgery
A validated shoulder-specific activity score (low 0 - 20 high)
12 months after surgery
American Shoulder and Elbow Surgeons Score
Time Frame: Prior to surgery
A validated joint specific patient-determined outcome score (low 0 - 100 high)
Prior to surgery
American Shoulder and Elbow Surgeons Score
Time Frame: 14 weeks after surgery
A validated joint specific patient-determined outcome score (low 0 - 100 high)
14 weeks after surgery
American Shoulder and Elbow Surgeons Score
Time Frame: 6 months after surgery
A validated joint specific patient-determined outcome score (low 0 - 100 high)
6 months after surgery
American Shoulder and Elbow Surgeons Score
Time Frame: 12 months after surgery
A validated joint specific patient-determined outcome score (low 0 - 100 high)
12 months after surgery
Single Assessment Numeric Evaluation
Time Frame: Prior to surgery
A validated general patient-determined outcome score (low 0 - 100 high)
Prior to surgery
Single Assessment Numeric Evaluation
Time Frame: 6 weeks after surgery
A validated general patient-determined outcome score (low 0 - 100 high)
6 weeks after surgery
Single Assessment Numeric Evaluation
Time Frame: 14 weeks after surgery
A validated general patient-determined outcome score (low 0 - 100 high)
14 weeks after surgery
Single Assessment Numeric Evaluation
Time Frame: 6 months after surgery
A validated general patient-determined outcome score (low 0 - 100 high)
6 months after surgery
Single Assessment Numeric Evaluation
Time Frame: 12 months after surgery
A validated general patient-determined outcome score (low 0 - 100 high)
12 months after surgery
Shoulder Activity Level
Time Frame: Prior to surgery
A validated shoulder-specific activity score (low 0 - 20 high)
Prior to surgery
Shoulder Activity Level
Time Frame: 14 weeks after surgery
A validated shoulder-specific activity score (low 0 - 20 high)
14 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Anticipated)

September 1, 2023

Study Completion (Anticipated)

September 1, 2024

Study Registration Dates

First Submitted

February 28, 2022

First Submitted That Met QC Criteria

February 28, 2022

First Posted (Actual)

March 10, 2022

Study Record Updates

Last Update Posted (Actual)

June 16, 2022

Last Update Submitted That Met QC Criteria

June 13, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Currently there is not a plan to allow IPD with other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Tears

Clinical Trials on Novel sling

Subscribe